Jodhpur C-section complications: 25 medicines suspended, AIIMS to probe
Synopsis
Eight women suffered serious complications after Caesarean deliveries at Jodhpur's Paota District Hospital, prompting authorities to suspend 25 medicines including Sodium Lactate IV drips. Two patients required dialysis and have been referred to AIIMS, which will conduct an independent probe — raising urgent questions about IV fluid quality control in government hospitals.
Key Takeaways
25 medicines and injections , including Sodium Lactate IV drips , suspended at Paota District Hospital, Jodhpur after complications emerged.
Eight women developed serious complications following Caesarean deliveries on 20 June .
Two patients — Lalita and Sonal — developed kidney impairment , required dialysis , and have been referred to AIIMS .
The implicated Sodium Lactate IV batch had arrived one week before the incident and was being used for the first time.
A team from AIIMS will conduct an independent investigation; surgeries at Paota District Hospital remain suspended pending lab reports.
Patients requiring surgery are being redirected to Mathuradas Mathur Hospital .
Health authorities have suspended the use of 25 medicines and injections — including Sodium Lactate IV drips routinely administered during Caesarean deliveries — at Paota District Hospital in Jodhpur, after eight women developed serious complications following childbirth on 20 June. Samples of all medicines and consumables used in the affected cases have been dispatched for laboratory testing, with officials directing that the suspended products remain unused until results are received.
What Triggered the Suspension
Preliminary findings indicate that the women were administered Sodium Lactate IV injections from a batch that had arrived at the hospital just one week before the incident and was being used for the first time, according to hospital authorities. The Medical Department has ordered an immediate halt to the entire batch as a precautionary measure pending a full investigation.
Family members of the affected women have alleged that patients experienced severe complications — including excessive bleeding and reduced urine output — shortly after delivery. Officials have stated that the exact cause of the complications is yet to be determined.
Condition of the Affected Women
According to hospital officials, six of the eight affected women are currently stable and showing signs of recovery. Two patients, identified as Lalita and Sonal, developed severe complications including kidney impairment and required dialysis treatment. Both have been referred to AIIMS for specialised care.
Senior Officials Review the Situation
District Collector Alok Ranjan visited the hospital's medicine store and chaired a review meeting with senior health officials. Those present included Dr B.S. Jodha, Principal of Dr SN Medical College; Dr Kulbir Chopra, PMO of Paota District Hospital; Dr Vikas Rajpurohit, Superintendent of MDM Hospital; and CMHO Dr S.S. Shekhawat.
Dr Kulbir Chopra stated that Sodium Lactate IV fluid is routinely administered before and after Caesarean deliveries and is also commonly used during other surgical procedures. He noted that all other medications and treatment protocols provided to the patients were standard and unchanged.
AIIMS Probe and Hospital Suspension
An inquiry has been initiated at the medical college level, and a team from AIIMS will conduct an independent investigation into the incident. Notably, surgical procedures at Paota District Hospital will remain suspended until reports on the medicines, consumables, and operation theatre environment are received. Patients requiring surgery are currently being referred to Mathuradas Mathur Hospital.
This incident has drawn sharp attention to quality-control mechanisms in government hospital supply chains, particularly for IV fluids used in obstetric care. The findings of the AIIMS probe are expected to determine whether the complications stemmed from a contaminated or substandard batch, or from other procedural factors.
Point of View
If confirmed, would point to a systemic gap rather than an isolated lapse. The referral of two patients to AIIMS for dialysis signals the severity that preliminary hospital-level reviews often understate. Until the AIIMS probe publishes its findings, the true cause — contamination, mislabelling, or procedural error — remains unresolved, and that ambiguity itself is a public health concern.
NationPress
23 Jun 2026
Frequently Asked Questions
What happened at Paota District Hospital in Jodhpur?
Eight women developed serious complications after undergoing Caesarean deliveries at Paota District Hospital in Jodhpur on 20 June. Health authorities subsequently suspended 25 medicines and injections, including Sodium Lactate IV drips, pending laboratory investigation.
Why were the medicines suspended?
Authorities suspended the medicines as a precautionary measure after preliminary findings linked the complications to a batch of Sodium Lactate IV injections that had arrived at the hospital one week before the incident. The batch was being used for the first time when the complications occurred.
What is the current condition of the affected women?
Six of the eight affected women are reported to be stable and recovering. Two patients, identified as Lalita and Sonal, developed kidney impairment and required dialysis; both have been referred to AIIMS for specialised care.
Who is investigating the incident?
An inquiry has been initiated at the medical college level, and a team from AIIMS will conduct an independent investigation. District Collector Alok Ranjan has also chaired a review meeting with senior health officials including the PMO, CMHO, and principals of the associated medical college.
Will surgeries continue at Paota District Hospital?
No. Surgical procedures at Paota District Hospital remain suspended until lab reports on the medicines, consumables, and operation theatre environment are received. Patients needing surgery are being referred to Mathuradas Mathur Hospital in the interim.
